IBTROZI™ (Taletrectinib), FDA-Approved Treatment, Available at Biologics by McKesson
Biologics by McKesson was selected as a limited specialty pharmacy provider for IBTROZI, a next-generation ROS1 inhibitor for adults with locally advanced or metastatic ROS1-positive non-small cell lung cancer.
AVMAPKI™ FAKZYNJA™ CO-PACK (avutometinib capsules; defactinib tablets,) FDA Approved for the Treatment of Adult Patients with KRAS-Mutated Recurrent Low-Grade Serous Ovarian Cancer who have Received Prior Systemic Therapy, Available at Biologics by McKesson
Biologics by McKesson was selected as a limited specialty pharmacy provider for AVMAPKI FAKZYNJA CO-PACK, approved for adults with KRAS-mutated recurrent low-grade serous ovarian cancer after prior systemic therapy.
VANRAFIA (atrasentan), FDA Approved for Adults with Immunoglobulin A Nephropathy, Available at Biologics by McKesson
Biologics by McKesson was selected as a limited specialty pharmacy provider for VANRAFIA, adding a treatment option for adults with immunoglobulin A nephropathy.